MiNK Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.5M | $40.2M | $38.9M |
| FY2022 | $21.9M | $21.5M | $19.6M |
| FY2023 | $22.6M | $4.6M | $3.4M |
| FY2024 | $25.3M | $5.7M | $4.6M |
| FY2025 | $28.5M | $14.2M | $13.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $16.5M | $40.2M | $38.9M |
| FY2022 | $21.9M | $21.5M | $19.6M |
| FY2023 | $22.6M | $4.6M | $3.4M |
| FY2024 | $25.3M | $5.7M | $4.6M |
| FY2025 | $28.5M | $14.2M | $13.4M |